share_log

GlaxoSmithKline | 20-F: FY2022 Annual Report

SEC ·  Mar 11, 2023 00:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more